Veracyte Announces Data to be Presented at PFF Summit 2015 Highlighting IPF Diagnostic Challenges and Potential of New Genomic-Based Testing Approaches

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. IBM

Go back to Veracyte Announces Data to be Presented at PFF Summit 2015 Highlighting IPF Diagnostic Challenges and Potential of New Genomic-Based Testing Approaches

Veracyte (VCYT) to See Possible Medicare Payment Cut; Leerink Partners Cuts Price Target to $11

November 6, 2015 8:24 AM EST

Leerink Partners maintained an Outperform rating on Veracyte, Inc (NASDAQ: VCYT), and cut the price target to $11.00 (from $13.00), following the company's 3Q earnings report. VCYT reported Q3 revenue of $12.3M, slightly below the Streets $12.6M. VCYT noted some additional wins with Blues plans in the... More